Latin America Empty Capsules Market Research Report – Segmented By Product, Therapeutic Application, End User & Country (Brazil, Mexico, Argentina, Chile and Rest of Latin America) – Industry Analysis (2025 to 2033)
The Latin America Empty Capsules Market Size was valued at USD 217.87 million in 2024. The Latin America Empty Capsules Market size is expected to have 7.6 % CAGR from 2025 to 2033 and be worth USD 421.22 million by 2033 from USD 234.43 million in 2025.
The Latin America Empty Capsules Market refers to the industry involved in the manufacturing and distribution of two-piece, hard-shell capsules used primarily in the pharmaceutical and nutraceutical sectors for encapsulating powders, granules, or liquids. These empty capsules serve as essential dosage forms due to their ease of use, rapid disintegration properties, and compatibility with a wide range of active ingredients. Moreover, the market includes both gelatin-based and plant-based (such as hydroxypropyl methylcellulose or HPMC) capsules, catering to diverse consumer preferences including vegetarian and halal dietary requirements.
The market is being shaped by growing health awareness and rising demand for self-medication across the region.
According to the Pan American Health Organization, the prevalence of chronic diseases such as diabetes and hypertension has increased significantly in Latin America over the past decade, leading to higher consumption of prescription and over-the-counter medications that often utilize capsule formulations.
Furthermore, regulatory improvements and investments in domestic drug manufacturing infrastructure are contributing to the steady expansion of the empty capsules market in Latin America.
A major factor contributing to the Latin America Empty Capsules Market is the rising prevalence of chronic diseases , particularly diabetes, cardiovascular disorders, and respiratory conditions, which have significantly increased the demand for oral solid dosage forms.
Also, non-communicable diseases account for a significant portion of all deaths in Latin America, with diabetes alone affecting a large number of people across the region. This growing patient base necessitates long-term medication regimens, many of which are delivered in capsule form due to their ease of swallowing, stability, and ability to mask unpleasant tastes.
Pharmaceutical manufacturers in Latin America are increasingly relying on empty capsules to develop cost-effective and scalable treatments tailored to regional disease burdens.
For example, as per the Brazilian Ministry of Health, public healthcare expenditures on chronic disease management rose considerable between 2019 and 2023, supporting greater production of encapsulated medicines. Similarly, in Mexico, according to the National Institute of Public Health, there is a sharp increase in prescriptions for hypertension and metabolic syndrome, further reinforcing the need for efficient capsule-based formulations.
A further catalyst behind the growth of the Latin America Empty Capsules Market is the expansion of the nutraceutical and dietary supplements industry, fueled by increasing health consciousness among urban populations and a growing middle class seeking preventive healthcare solutions.
Consumers are increasingly opting for encapsulated vitamins, minerals, herbal extracts, and functional ingredients that offer convenience, precise dosing, and minimal preservatives.
This shift is particularly evident among younger demographics and fitness-conscious individuals who prefer customized health products.
Similarly, in Argentina and Chile, rising disposable incomes and improved access to online health platforms have contributed to a broader adoption of capsule-based supplements.
Apart from these, the growth of compounding pharmacies has played a crucial role in expanding the usage of empty capsules. These pharmacies customize medication blends based on individual patient needs, offering tailored solutions that are not available in mass-produced formats.
One of the major restraints affecting the Latin America Empty Capsules Market is the high cost of raw materials and supply chain disruptions , which impact production efficiency and pricing stability. Empty capsules are primarily made from gelatin or plant-based polymers like HPMC, both of which depend on global commodity markets and agricultural inputs.
Also, fluctuations in bovine and porcine feedstock prices—used in animal-derived gelatin—have led to volatility in capsule manufacturing costs.
Additionally, geopolitical tensions and trade restrictions have disrupted the import of key raw materials, particularly in countries like Venezuela and Argentina, where currency devaluation complicates international procurement.
Moreover, the logistical challenges in regional distribution further hinder market growth. Many Latin American countries face infrastructural limitations, including inadequate cold-chain storage and inconsistent transportation networks, which affect the timely delivery of temperature-sensitive capsule materials.
Delays at customs and inconsistent regulatory enforcement across borders add complexity to cross-country supply chains. These factors collectively contribute to increased operational costs and reduced profit margins for local manufacturers. While some companies are investing in localized sourcing and vertical integration strategies, the persistent instability in raw material availability and logistics remains a significant barrier to market expansion in Latin America.
Another significant restraint influencing the Latin America Empty Capsules Market is the limited regulatory harmonization across regional markets, which creates compliance complexities for manufacturers and distributors. Unlike the European Union or the United States, where standardized guidelines govern pharmaceutical packaging and formulation, Latin American countries maintain distinct regulatory frameworks that vary in approval processes, labeling requirements, and quality control standards.
Like, inconsistencies in regulatory oversight among Mercosur nations—such as Brazil, Argentina, Paraguay, and Uruguay—often lead to delays in product registration and market entry. Countries like Colombia and Peru have also introduced evolving Good Manufacturing Practice (GMP) norms that require frequent adjustments in capsule production protocols. This fragmented landscape increases administrative burdens and raises the cost of compliance for multinational suppliers looking to scale operations in the region.
Furthermore, the lack of uniform pharmacopeial standards affects product acceptance and export potential. As noted by the International Society for Pharmaceutical Engineering, discrepancies in dissolution testing, microbial limits, and excipient specifications can result in rejected shipments or re-formulation requirements.
One of the key opportunities in the Latin America Empty Capsules Market lies in the growing demand for plant-based and vegan-friendly capsules , driven by shifting consumer preferences toward ethical, sustainable, and religiously compliant healthcare products. Traditional gelatin capsules, typically derived from animal sources, are increasingly being replaced by alternatives made from cellulose derivatives such as HPMC and starch-based polymers.
According to the Vegconomist - the vegan business magazine, the number of vegetarians and vegan establishments in the Latin America has grown significantly, particularly in urban centers like São Paulo, Mexico City, and Buenos Aires.
This trend is especially prominent among younger consumers who prioritize transparency, clean-label ingredients, and cruelty-free formulations. In response, major pharmaceutical and nutraceutical brands are reformulating their products to accommodate these preferences.
Additionally, Halal certification requirements in certain markets are pushing manufacturers to adopt alternative capsule technologies that meet religious dietary guidelines.
With increasing investment in biopolymer research and development, local and international suppliers are well-positioned to capitalize on this opportunity.
Another notable opportunity shaping the Latin America Empty Capsules Market is the expansion of contract manufacturing organizations (CMOs) and compounding pharmacies , which are playing an increasingly vital role in drug formulation and personalized medicine. As pharmaceutical companies outsource production to reduce capital expenditure and streamline operations, CMOs are emerging as key facilitators in the manufacturing and filling of empty capsules with customized formulations.
Moreover, the number of certified contract manufacturers in the region grew notably between 2020 and 2023, with Brazil and Mexico accounting for the majority of this expansion. These facilities cater to both local and international clients, offering flexible, small-batch production capabilities that align with the growing demand for niche and specialized medications.
Compounding pharmacies are also gaining traction, particularly in response to patient-specific therapeutic needs. As regulatory bodies begin to formalize compounding practices and ensure quality control, the utilization of empty capsules is expected to rise significantly, presenting a strong growth avenue for suppliers across Latin America.
One of the major challenges facing the Latin America Empty Capsules Market is the intense competition from alternative dosage forms , such as tablets, softgels, and liquid-filled capsules, which are often preferred for their perceived advantages in terms of stability, ease of manufacturing, and consumer familiarity. Tablets, in particular, dominate the pharmaceutical market due to their cost-effectiveness and scalability in large-scale production.
Softgel capsules also pose a challenge, especially in the nutraceutical and hormone replacement therapy segments, where they offer superior sealing properties and enhanced bioavailability. These alternative formats benefit from established consumer trust and extensive distribution networks, making them formidable competitors to traditional hard-shell empty capsules.
Besides, liquid-filled capsules and orally disintegrating tablets (ODTs) are gaining popularity due to their faster onset of action and suitability for pediatric and geriatric patients.
Another critical challenge confronting the Latin America Empty Capsules Market is the slow adoption of advanced capsule technologies , particularly moisture-resistant, enteric-coated, and modified-release formulations, due to limited technical expertise, high equipment costs, and regulatory inertia. While developed markets such as North America and Europe have widely integrated these innovations to enhance drug performance and patient compliance, Latin American manufacturers often lag behind due to financial constraints and knowledge gaps.
As noted by the Latin American Academy of Sciences, many local pharmaceutical firms lack the necessary infrastructure to implement sophisticated coating techniques or invest in high-speed encapsulation machines. This results in continued reliance on conventional capsule types that may be less effective for certain drug delivery applications. Moreover, the absence of widespread training programs and technical support networks hinders the transition to more advanced formulations.
Regulatory agencies in the region also struggle to keep pace with technological advancements, leading to delayed approvals for novel capsule designs.
These delays discourage investment in innovation and limit the availability of next-generation capsule products in Latin America, posing a structural challenge to market modernization and competitiveness.
| REPORT METRIC | DETAILS |
| Market Size Available | 2024 to 2033 |
| Base Year | 2024 |
| Forecast Period | 2025 to 2033 |
| CAGR | 7.6 % |
| Segments Covered | By Product, Therapeutic Application, End User and Country. |
| Various Analyses Covered | Global, Regional, & Country Level Analysis; Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Country Covered | Mexico, Brazil, Argentina, Chile, Peru and Rest of Latin America. |
| Market Leaders Profiled | Capsugel, ACG Worldwide, Suheung Co Ltd., Bright Pharmacaps Inc |
The gelatin capsules segment commanded the Latin America empty capsules market, holding a 68.1% of total market share in 2024, due to their long-standing use in pharmaceutical and nutraceutical formulations. Also, gelatin-based capsules are favored for their excellent mechanical properties, biocompatibility, and ability to dissolve quickly in the gastrointestinal tract, ensuring rapid drug release and bioavailability.
One key driver behind this dominance is the established presence of traditional pharmaceutical manufacturing in countries like Brazil and Mexico , where gelatin remains the most widely used material for capsule production.
Besides, the availability of cost-effective animal-derived gelatin from regional livestock industries supports widespread usage. This accessibility ensures lower production costs compared to plant-based alternatives, making gelatin capsules particularly attractive to budget-conscious pharmaceutical firms operating in emerging markets.
Moreover, regulatory familiarity with gelatin-based formulations reduces approval timelines and facilitates quicker market entry. As a result, despite rising interest in alternative materials, gelatin capsules continue to dominate the Latin American market, driven by legacy infrastructure, raw material availability, and regulatory consistency.
On the other hand, the non-gelatin capsules segment is projected to grow at the fastest compound annual growth rate (CAGR) of 9.4% between 2025 and 2033, fueled by increasing demand for vegetarian, vegan-friendly, and religiously compliant alternatives. These capsules, typically made from hydroxypropyl methylcellulose (HPMC), starch derivatives, or pullulan, are gaining traction across both pharmaceutical and nutraceutical sectors.
A major catalyst for this growth is the rising consumer awareness around ethical and dietary preferences, particularly among younger, health-conscious populations. Also, pharmaceutical and supplement brands have reformulated products to accommodate these preferences, driving demand for non-gelatin capsules.
Another contributing factor is the growing influence of Halal and Kosher certification requirements , which discourage the use of animal-derived ingredients.
Furthermore, increased investment in biopolymer research and development has improved the performance characteristics of non-gelatin capsules, including moisture resistance and stability under varying conditions. As a result, manufacturers are increasingly adopting these alternatives to meet evolving consumer expectations while complying with global quality standards, positioning non-gelatin capsules as the fastest-growing segment in the Latin American market.
The Vitamins & Dietary Supplements therapeutic application segment led the Latin America empty capsules market, accounting for 34% of total demand in 2024 , driven by rising health consciousness, preventive healthcare adoption, and the expansion of the nutraceutical industry.
One of the leading drivers is the surge in consumer interest in wellness and immunity-boosting supplements, particularly following the global pandemic. According to Euromonitor International, the Latin American dietary supplements market grew by over 15% between 2020 and 2023 , with Brazil and Mexico leading consumption. Consumers are increasingly turning to encapsulated vitamins, minerals, herbal extracts, and functional ingredients that offer convenience, precise dosing, and minimal preservatives.
This trend is especially pronounced among younger demographics and fitness-oriented individuals who prefer customized health products.
Besides, the rise of compounding pharmacies offering personalized vitamin blends has further boosted demand for empty capsules. These pharmacies customize medication and supplement combinations based on individual patient needs, allowing for tailored solutions not available in mass-produced formats.
On the other hand, the Cardiovascular Therapy Drugs segment is expected to grow at the highest CAGR of 9.1%, driven by the rising prevalence of hypertension, heart disease, and metabolic syndrome across Latin America. Cardiovascular diseases remain the leading cause of mortality in the region, necessitating long-term pharmacological interventions delivered through reliable dosage forms such as capsules.
One of the key growth factors is the expanding elderly population , particularly in Brazil and Argentina, where life expectancy has steadily increased over the past two decades. Capsule-based formulations offer advantages such as ease of swallowing, accurate dosing, and compatibility with modified-release technologies, making them ideal for chronic disease management.
In addition, government initiatives aimed at improving access to essential medicines are supporting the uptake of cardiovascular drugs in public health programs.
Moreover, pharmaceutical companies are investing in targeted therapies and combination treatments for hypertension and hyperlipidemia, often utilizing capsules for formulation flexibility. As awareness of cardiovascular risk factors grows and healthcare systems prioritize early intervention, the demand for cardiovascular therapy drugs—and consequently, empty capsules—is expected to accelerate significantly.
The Pharmaceutical Industry was the prevailing end-user segment in the Latin America empty capsules market , capturing 58.7% of total demand in 2024, driven by the widespread use of capsules in prescription and generic drug formulations. Capsules are preferred for their ability to deliver precise dosages, mask unpleasant tastes, and ensure rapid disintegration, making them a staple in modern pharmaceutical manufacturing.
One of the key contributors to this dominance is the strong presence of generic drug manufacturers in the region , particularly in Brazil and Mexico.
Additionally, public healthcare programs across Latin America are expanding access to essential medicines , many of which are formulated in capsules for stability and patient compliance. As per the Pan American Health Organization, several governments have introduced policies to strengthen domestic pharmaceutical production, encouraging investment in capsule filling lines and related infrastructure.
Moreover, capsules offer formulation flexibility for modified-release and multi-layered drug delivery , aligning with advancements in chronic disease management. As the pharmaceutical sector continues to expand and innovate, the reliance on high-quality empty capsules remains a cornerstone of drug manufacturing in Latin America.
Among end users, the Nutraceutical Industry is expected to grow at the fastest CAGR of 9.8%, driven by increasing consumer demand for preventive healthcare, wellness-focused supplements, and functional foods. The rising popularity of encapsulated vitamins, herbal extracts, and specialty nutrients is fueling market expansion across Latin America.
A primary growth driver is the shift toward self-medication and natural health remedies , particularly among millennials and health-conscious consumers. Consumers are increasingly seeking clean-label, plant-based, and certified products, prompting manufacturers to adopt high-quality empty capsules that align with these preferences.
Additionally, the rise of e-commerce platforms specializing in health and wellness products has expanded access to encapsulated nutraceuticals. Platforms such as iHerb, Amazon Health, and local players like Mundo Verde in Mexico and Natue in Brazil have seen significant growth, facilitating direct-to-consumer supplement sales that rely heavily on capsule-based formulations.
Moreover, compounding pharmacies and private wellness clinics are integrating nutraceutical-grade capsules into personalized treatment plans , enhancing their credibility and appeal. As awareness of preventive health grows and regulatory frameworks evolve to support product safety and transparency, the nutraceutical segment is poised to lead the next phase of growth in the Latin America empty capsules market.
Brazil held the largest share of the Latin America empty capsules market , accounting for 35.7% of regional demand in 2024 , driven by its well-developed pharmaceutical industry, growing nutraceutical sector, and strong domestic manufacturing base. As one of the top ten pharmaceutical producers globally, Brazil plays a central role in shaping capsule consumption patterns across the continent.
The country’s generic drug industry remains a key pillar of capsule demand , supported by government policies promoting affordable medicines. Additionally, ANVISA has been actively encouraging local manufacturing to reduce import dependency, resulting in increased investments in capsule filling and packaging facilities.
Simultaneously, the nutraceutical and dietary supplements market is experiencing rapid growth. This surge is being driven by a rising middle class, increased health awareness, and the expansion of online health retailers.
Moreover, Brazil is witnessing a boom in compounding pharmacies , which personalize medication and supplement blends using empty capsules.
Mexico contributes approximately 24% of the Latin America empty capsules market , maintaining a strong presence due to its robust pharmaceutical exports, expanding nutraceutical industry, and increasing domestic consumption of encapsulated medicines and supplements.
One of the key drivers is the country’s integration into North American pharmaceutical supply chains , particularly under the USMCA trade agreement.
Additionally, the growth of the nutraceutical sector is accelerating. E-commerce platforms such as SaludClick and Farmalisto have played a crucial role in expanding access to encapsulated products.
Moreover, government initiatives to improve public health access are influencing capsule demand. With continued investment in healthcare and pharmaceutical manufacturing, Mexico is positioned to maintain steady growth in the empty capsules market.
Argentina accounts for around 14% of the Latin America empty capsules market , maintaining a notable presence due to its well-established pharmaceutical sector, increasing nutraceutical demand, and growing emphasis on domestic drug production.
The country’s pharmaceutical industry benefits from a strong tradition of research and development , particularly in the formulation of generic medicines. Government incentives to boost local manufacturing have also encouraged investment in capsule filling technology.
In addition, the nutraceutical market is gaining momentum. This growth is attributed to rising health consciousness, particularly among urban professionals and aging populations seeking preventive healthcare solutions.
Moreover, compounding pharmacies are playing an increasingly important role in personalized medicine. These pharmacies frequently use empty capsules to prepare customized formulations tailored to individual patient needs, further strengthening market demand in Argentina.
Chile is benefiting from its advanced healthcare system, stringent pharmaceutical regulations, and growing focus on preventive health solutions. As one of the most developed economies in the region, Chile offers a favorable environment for pharmaceutical and nutraceutical innovation.
The country’s healthcare system ranks among the best in Latin America , with universal coverage and high standards for drug quality assurance.
Additionally, the nutraceutical industry is expanding rapidly , supported by rising disposable incomes and increased awareness of dietary supplements.
Furthermore, Chilean regulatory agencies enforce strict Good Manufacturing Practice (GMP) standards , ensuring high-quality capsule production. The ISP has implemented rigorous approval processes for pharmaceutical and nutraceutical products, encouraging manufacturers to adopt premium capsule materials and advanced encapsulation techniques. As a result, Chile is emerging as a key player in the Latin American empty capsules market.
The remaining Latin American countries collectively account for a notable share of the regional empty capsules market , with Colombia, Peru, Ecuador, and Costa Rica showing promising growth trajectories. While still in early stages compared to Brazil, Mexico, and Argentina, these markets are experiencing gradual adoption of capsule-based formulations due to rising health awareness and increasing investments in pharmaceutical infrastructure.
Colombia, in particular, has seen a notable increase in pharmaceutical manufacturing activity. The country’s expanding middle class and government-backed healthcare expansion programs are contributing to higher capsule demand.
In Peru, the growth of nutraceutical startups is influencing fermentation practices, with companies exploring bacterial cultures for oat and quinoa-based drinks.
Despite challenges such as limited technical expertise and regulatory inconsistencies, these markets are gradually embracing standardized capsule production methods. As consumer preferences evolve and local production capabilities improve, the Rest of Latin America is expected to contribute more significantly to the overall growth of the empty capsules market in the coming years.
A few prominent companies in the Latin America empty capsules market profiled in this report are Capsugel, ACG Worldwide, Suheung Co Ltd., Bright Pharmacaps Inc., Capscanada Corporation, Medi-Caps Ltd., Qualicaps, Roxlor, LLC, Snail Pharma Industry Co.Ltd, and Sunil Healthcare Limited.
The Latin America empty capsules market features a competitive landscape shaped by the presence of both global leaders and regional manufacturers striving to meet the increasing demand for high-quality encapsulation solutions. Multinational corporations such as Lonza (through Capsugel), Aenova, and Qualicaps have established strong footholds due to their extensive R&D capabilities, advanced production technologies, and adherence to international quality standards. Their presence ensures a steady flow of innovative products, including moisture-resistant and modified-release capsules that cater to complex drug delivery needs.
Capsugel (now a part of Lonza Group)
Capsugel has long been recognized as a global leader in capsule manufacturing and continues to play a significant role in shaping the Latin American empty capsules market. The company is known for its high-quality gelatin and plant-based capsule solutions tailored for pharmaceutical and nutraceutical applications. In Latin America, Capsugel’s presence has helped set industry benchmarks in terms of innovation, regulatory compliance, and formulation flexibility.
Aenova Group
Aenova Group contributes significantly to the Latin American market by supplying premium empty capsules and offering contract development and manufacturing services. With a focus on customized dosage forms, Aenova supports regional pharmaceutical companies in launching efficient and patient-friendly capsule-based products. Its commitment to quality assurance and scalable production aligns with the growing demand for reliable encapsulation solutions across the region.
Qualicaps Co., Ltd.
Qualicaps is a major player in advanced capsule technologies and has expanded its influence in Latin America through strategic partnerships and localized service offerings. Known for its precision-engineered capsules and investment in alternative materials such as HPMC, Qualicaps plays a key role in supporting the transition toward vegetarian and Halal-compliant formulations in the region. Its customer-centric approach enhances its reputation among pharmaceutical and nutraceutical formulators.
Expansion Through Strategic Partnerships and Collaborations
Leading players are increasingly forming alliances with regional pharmaceutical manufacturers, research institutions, and packaging firms to enhance their market reach and accelerate product adoption. These collaborations help bridge knowledge gaps, improve supply chain efficiency, and align capsule development with evolving consumer and regulatory expectations across Latin America.
Investment in Sustainable and Plant-Based Capsule Technologies
With rising demand for ethical and dietary-compliant alternatives, companies are directing resources toward developing non-gelatin capsules using cellulose derivatives and other biopolymers. This shift not only caters to niche consumer preferences but also strengthens brand positioning in markets where religious and lifestyle-driven choices are gaining importance.
Strengthening Local Manufacturing and Distribution Networks
To reduce dependency on imports and ensure faster delivery, major capsule suppliers are investing in regional production hubs and logistics infrastructure. By localizing operations, companies can better serve emerging markets, comply with local regulations, and offer cost-competitive solutions tailored to the specific needs of Latin American customers.
In February 2024, Lonza (formerly Capsugel) launched a new line of high-moisture-resistant HPMC capsules designed specifically for tropical climates, addressing stability concerns in regions like Brazil and Colombia where humidity poses formulation challenges.
In June 2023, Aenova Group expanded its regional distribution network by partnering with a leading pharmaceutical logistics provider in Mexico, enhancing delivery efficiency and responsiveness to local manufacturers requiring just-in-time capsule supply.
In September 2023, Qualicaps introduced a pilot program with a Brazilian nutraceutical brand to integrate smart capsule technology that allows consumers to track ingredient sources and verify authenticity via QR code scanning, enhancing transparency and consumer trust.
In January 2024, Shionogi & Co. partnered with a Chilean compounding pharmacy association to provide training modules on advanced capsule filling techniques, aiming to boost the adoption of high-quality encapsulated formulations in personalized medicine.
In May 2024, Suheung Capsule Co. opened a regional sales office in Argentina to strengthen its presence in South America, supporting local pharmaceutical companies with tailored capsule solutions and technical support.
This research report on the Latin America empty capsules market has been segmented and sub-segmented into the following categories
By Product
By Therapeutic Application
By End User
By Country
Frequently Asked Questions
Key drivers include the rising demand for dietary supplements, increasing health awareness, pharmaceutical innovations, and a growing geriatric population.
Brazil, Mexico, and Argentina are the major contributors due to large pharmaceutical industries and increasing health-conscious populations.
The pharmaceutical segment dominates, especially for antibiotics, anti-inflammatory drugs, and pain relievers.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 1600
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region